Detalles de la búsqueda
1.
Sepax-2 cell processing device: a study assessing reproducibility of concentrating thawed hematopoietic progenitor cells.
J Transl Med
; 20(1): 503, 2022 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36329460
2.
Validation of a flow cytometry-based method to quantify viable lymphocyte subtypes in fresh and cryopreserved hematopoietic cellular products.
Cytotherapy
; 23(1): 77-87, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32718876
3.
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients.
Biol Blood Marrow Transplant
; 25(9): 1803-1809, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31128325
4.
Validation of a semi automatic device to standardize quantification of Colony-Forming Unit (CFU) on hematopoietic stem cell products.
Cytotherapy
; 21(8): 820-823, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31257121
5.
A matched-pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institution.
Transfusion
; 59(11): 3442-3447, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31625183
6.
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison.
Biol Blood Marrow Transplant
; 24(7): 1449-1454, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29448057
7.
Killer Cell Immunoglobulin-Like Receptor-Ligand Mismatch in Donor versus Recipient Direction Provides Better Graft-versus-Tumor Effect in Patients with Hematologic Malignancies Undergoing Allogeneic T Cell-Replete Haploidentical Transplantation Followed by Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
; 24(3): 549-554, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29247781
8.
Pre-clinical assessment of the Lovo device for dimethyl sulfoxide removal and cell concentration in thawed hematopoietic progenitor cell grafts.
Cytotherapy
; 19(12): 1501-1508, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29037941
9.
Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated Donor.
Biol Blood Marrow Transplant
; 22(1): 119-24, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26341397
10.
Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies.
Cancer
; 121(11): 1809-16, 2015 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25649994
11.
CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies.
Biol Blood Marrow Transplant
; 20(3): 382-6, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24321747
12.
Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.
Biol Blood Marrow Transplant
; 20(10): 1560-5, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24933658
13.
Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host disease.
Biol Blood Marrow Transplant
; 20(3): 370-4, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24315846
14.
Prophylactic donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation for high risk haematological malignancies: a retrospective bicentric analysis of serial infusions of increasing doses of CD3+ cells.
Br J Haematol
; 185(3): 570-573, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30125934
15.
Assessing the HLA diversity of cord blood units collected from a birth clinic caring for pregnant women in an ethnically diverse metropolitan area.
Transfusion
; 54(4): 1046-54, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23944705
16.
A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor.
Am J Hematol
; 89(1): 83-7, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24108528
17.
[Academic cell therapy facilities are challenged by European regulation on advanced therapy medicinal products]. / Les unités de thérapie cellulaire à l'épreuve de la réglementation sur les médicaments de thérapie innovante.
Med Sci (Paris)
; 30(5): 576-83, 2014 May.
Artículo
en Francés
| MEDLINE | ID: mdl-24939546
18.
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease.
Bone Marrow Transplant
; 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38486114
19.
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome.
Bone Marrow Transplant
; 59(1): 101-106, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37923831
20.
Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma.
Am J Hematol
; 88(5): 370-4, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23460414